Da Volterra is committed to supporting innovation and growth to prevent C. difficile infections and is honored to sponsor the C. diff Awareness Conference and Health Expo organized by the C. diff Foundation November 9th-10th, 2017 in Las Vegas. Several key opinion leaders will speak at this event on how to combat CDIs.
In order to prevent devastating CDIs, Da Volterra is advancing clinical development for DAV132 which aims to prevent CDIs by protection of the intestinal microbiota. DAV132 has demonstrated excellent safety in four Phase 1 clinical trials. To learn more about DAV132 please follow the link.